Medicine/Health

      Hebrew University Research Could Offer New Cancer Treatment Option

      PRINT Created with Sketch.
      PRINT

      Hebrew University Research Could Offer New Cancer Treatment Option

      PRINT Created with Sketch.
      PRINT

      It is a feeling that many who receive a cancer diagnosis can identify with: heartbreak and fear, followed by hopes that chemotherapy will save the day. Unfortunately for many patients, chemo’s painful side effects cause them to stop treatment prematurely.

      Now, a research team headed by Professor Alexander Binshtok, head of the Pain Plasticity Research Group at the Hebrew University of Jerusalem’s Faculty of Medicine and Edmond & Lily Safra Center for Brain Sciences, has developed a method that delivers chemotherapy drugs directly to malignant cells and bypasses healthy ones. This discovery could allow doctors to reduce chemo doses for patients, thereby reducing the unpleasant side-effects associated with the treatment, and improve treatment compliance and overall prognoses.

      “Most anti-cancer treatments are not sufficiently specific, meaning they attack healthy cells together with the malignant ones they’re trying to get rid of,” explained Binshtok.  “This leads to the many serious side-effects associated with chemotherapy. Eliminating cancerous cells while leaving healthy ones alone is an important step towards reducing patients’ suffering.”

      Prof. Alexander Binshtok in his lab.
      Credit: Hadas Parush/Flash90

      The new findings were published in a recent issue of Frontiers in Pharmacology.  The study focuses on the selective expression of the TRPV2 protein by cancer cells.  When activated, TRPV2 protein opens a canal inside cell membranes. Binshtok and his team studied liver cancer cells and were able to successfully insert a low dose of doxorubicin, a chemotherapeutic agent, through the canal and directly into cancer cells. Not only did the new method target cancer cells without harming healthy ones. In the future, the precision of this delivery method may allow doctors to prescribe lower chemo doses and to relieve patients from some of the harsher effects of chemo.

      “It’s too early to make concrete predictions but we are hopeful this discovery will lead the way towards a new, more targeted delivery method for chemotherapy treatment, one that will drastically reduce patients’ pain,” Binshtok concluded.

      TRPV2 protein in action.
      Credit: Dr. David Roberson & Prof. Alex Binshtok

      ###

      CITATION:  2-APB and CBD-Mediated Targeting of Charged Cytotoxic Compounds Into Tumor Cells Suggests the Involvement of TRPV2 Channels. Hagit Neumann-Raziel, Asaf Shilo, Shaya Lev, Maxim Mogilevsky, Ben Katz, David Shneor, Yoav D. Shaul, Andreas Leffler, Alberto Gabizon, Rotem Karni, Alik Honigman, and Alexander M. Binshtok, Frontiers in Pharmacologyhttps://doi.org/10.3389/fphar.2019.01198

      FUNDING: Deutsche Forschungsgemeinschaft (DIP), Israel Science Foundation, Marie Curie International Reintegration Grant, Rosetrees Trust.

      SHARE

      RELATED ARTICLES

      Cybersecurity and Health Research: Cooperation between...

      Cybersecurity and Health Research:...

      READ MORE

      Virginia Tech and Hebrew University of Jerusalem to...

      Virginia Tech and Hebrew University of...

      READ MORE

      A Pioneering Partnership in Nanomedicine

      A Pioneering Partnership in Nanomedicine

      READ MORE

      Hebrew University and University of Maryland Sign...

      Hebrew University and University of...

      READ MORE

      Zuckerman Scholars Program

      Zuckerman Scholars Program

      READ MORE

      HU and Freie Universität Berlin Expand Strategic...

      HU and Freie Universität Berlin Expand...

      READ MORE

      Thomas Jefferson University and HU’s Faculty of...

      Thomas Jefferson University and...

      READ MORE

      German and Israeli research leaders launch Global...

      German and Israeli research leaders...

      READ MORE

      Latin American academic leaders sign cooperation agreements...

      Latin American academic leaders sign...

      READ MORE
      X WHITE Copy Created with Sketch. X
      Lightbox Increment Created with Sketch.
      Arrow NEXT-image Created with Sketch.